CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...